Analysen von Richard Vosser
| 14.04.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 07.04.25 | Novartis Neutral | JP Morgan Chase & Co. | |
| 07.04.25 | Bayer Neutral | JP Morgan Chase & Co. | |
| 03.04.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 28.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 26.03.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 26.03.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 25.03.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 24.03.25 | Bayer Neutral | JP Morgan Chase & Co. | |
| 17.03.25 | Bayer Neutral | JP Morgan Chase & Co. | |
| 12.03.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 10.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.03.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 06.03.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 05.03.25 | Bayer Neutral | JP Morgan Chase & Co. | |
| 26.02.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 26.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 25.02.25 | Novartis Neutral | JP Morgan Chase & Co. | |
| 18.02.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 14.02.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 12.02.25 | Bayer Neutral | JP Morgan Chase & Co. | |
| 10.02.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 07.02.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 06.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.02.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 30.01.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 30.01.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 29.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.01.25 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 29.01.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 28.01.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 27.01.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 24.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 24.01.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 21.01.25 | Bayer Neutral | JP Morgan Chase & Co. | |
| 20.01.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 20.01.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 17.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.01.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 16.01.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 14.01.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 10.01.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 06.01.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 06.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.01.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 19.12.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 17.12.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 16.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 11.12.24 | Merck Overweight | JP Morgan Chase & Co. | |